$16.05
1.26% today
Nasdaq, Aug 18, 08:16 pm CET
ISIN
US5907171046
Symbol
MESO

Mesoblast Limited Sponsored ADR Target price 2025 - Analyst rating & recommendation

Mesoblast Limited Sponsored ADR Classifications & Recommendation:

Buy
78%
Hold
22%

Mesoblast Limited Sponsored ADR Price Target

Target Price $2.02
Price $16.25
Deviation
Number of Estimates 3
3 Analysts have issued a price target Mesoblast Limited Sponsored ADR 2026 . The average Mesoblast Limited Sponsored ADR target price is $2.02. This is lower than the current stock price. The highest price target is , the lowest is .
A rating was issued by 9 analysts: 7 Analysts recommend Mesoblast Limited Sponsored ADR to buy, 2 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Mesoblast Limited Sponsored ADR stock has an average upside potential 2026 of . Most analysts recommend the Mesoblast Limited Sponsored ADR stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Jun '24 2025
Estimates
Revenue Million $ 5.90 16.36
21.33% 177.32%
EBITDA Margin -1,108.98% -372.85%
35.77% 66.38%
Net Margin -1,490.85% -2,838.42%
36.54% 90.39%

5 Analysts have issued a sales forecast Mesoblast Limited Sponsored ADR 2025 . The average Mesoblast Limited Sponsored ADR sales estimate is

$16.4m
Unlock
. This is
188.57% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$20.2m 255.56%
Unlock
, the lowest is
$12.7m 124.69%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $5.9m 21.33%
2025
$16.4m 177.32%
Unlock
2026
$67.7m 314.04%
Unlock
2027
$246m 262.53%
Unlock
2028
$547m 122.75%
Unlock
2029
$510m 6.74%
Unlock
2030
$803m 57.39%
Unlock
2031
$1.3b 58.79%
Unlock
2032
$938m 26.41%
Unlock

5 Mesoblast Limited Sponsored ADR Analysts have issued a net profit forecast 2025. The average Mesoblast Limited Sponsored ADR net profit estimate is

$-464m
Unlock
. This is
349.37% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-79.9m 22.73%
Unlock
, the lowest is
$-824m 697.74%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-88.0m 7.41%
2025
$-464m 427.99%
Unlock
2026
$-258m 44.42%
Unlock
2027
$8.5m 103.30%
Unlock
2028
$348m 3,985.46%
Unlock

Net Margin

2024 -1,490.85% 36.54%
2025
-2,838.42% 90.39%
Unlock
2026
-381.00% 86.58%
Unlock
2027
3.47% 100.91%
Unlock
2028
63.70% 1,735.73%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Jun '24 2025
Estimates
Earnings Per Share $ -0.09 -0.40
18.18% 344.44%
P/E negative
EV/Sales 129.02

5 Analysts have issued a Mesoblast Limited Sponsored ADR forecast for earnings per share. The average Mesoblast Limited Sponsored ADR EPS is

$-0.40
Unlock
. This is
344.44% lower
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$-0.07 22.22%
Unlock
, the lowest is
$-0.72 700.00%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-0.09 18.18%
2025
$-0.40 344.44%
Unlock
2026
$-0.22 45.00%
Unlock
2027
$0.01 104.55%
Unlock
2028
$0.30 2,900.00%
Unlock

P/E ratio

Current -180.56 163.37%
2025
-40.32 77.67%
Unlock
2026
-72.56 79.96%
Unlock
2027
2,194.97 3,125.04%
Unlock
2028
53.74 97.55%
Unlock

Based on analysts' sales estimates for 2025, the Mesoblast Limited Sponsored ADR stock is valued at an EV/Sales of

129.02
Unlock
and an P/S ratio of
123.61
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 372.30 185.35%
2025
129.02 65.35%
Unlock
2026
31.16 75.85%
Unlock
2027
8.60 72.42%
Unlock
2028
3.86 55.11%
Unlock
2029
4.14 7.23%
Unlock
2030
2.63 36.46%
Unlock
2031
1.66 37.02%
Unlock
2032
2.25 35.88%
Unlock

P/S ratio

Current 356.70 195.00%
2025
123.61 65.35%
Unlock
2026
29.85 75.85%
Unlock
2027
8.23 72.42%
Unlock
2028
3.70 55.11%
Unlock
2029
3.96 7.23%
Unlock
2030
2.52 36.46%
Unlock
2031
1.59 37.02%
Unlock
2032
2.16 35.89%
Unlock

Current Mesoblast Limited Sponsored ADR Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
BELL POTTER SECURITIES
Locked
Locked
Locked Jul 17 2025
CANTOR FITZGERALD
Locked
Locked
Locked Jul 17 2025
JEFFERIES
Locked
Locked
Locked Jul 17 2025
PIPER SANDLER COMPANIES
Locked
Locked
Locked Jul 08 2025
MAXIM GROUP
Locked
Locked
Locked Jul 02 2025
PIPER SANDLER COMPANIES
Locked
Locked
Locked Apr 06 2025
JEFFERIES
Locked
Locked
Locked Mar 05 2025
Analyst Rating Date
Locked
BELL POTTER SECURITIES:
Locked
Locked
Jul 17 2025
Locked
CANTOR FITZGERALD:
Locked
Locked
Jul 17 2025
Locked
JEFFERIES:
Locked
Locked
Jul 17 2025
Locked
PIPER SANDLER COMPANIES:
Locked
Locked
Jul 08 2025
Locked
MAXIM GROUP:
Locked
Locked
Jul 02 2025
Locked
PIPER SANDLER COMPANIES:
Locked
Locked
Apr 06 2025
Locked
JEFFERIES:
Locked
Locked
Mar 05 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today